filmov
tv
Coronavirus:FDA approves $5 rapid COVID-19 antigen test for emergency use authorization from Abbott
Показать описание
Dr. Soren Christiansen, former Head of Vaccines at Merck and CEO of Sharps Technology, joined The Final Round to discuss the latest developments regarding a COVID-19 vaccine and his thoughts on the FDA approving Abbott's rapid coronavirus test.
#coronavirustest #COVID19testing #rapidcoronavirustesting
Video Transcript
SEANA SMITH: Let's get to another big story of the day. We talk about all these factors that are influencing the market. One, we had the Fed, but then we also had this big announcement out from Abbott. And we saw the reaction in Abbot's shares today, the stock up almost 8% on this news. Now, the news coming that Abbott has now gained FDA authorization for a $5 rapid coronavirus test.
Now, here to talk a little bit more about this and also finding a COVID-19 vaccine, I want to bring in Dr. Soren Christiansen, former Head of Vaccines at Merck. He's now the CEO of Sharps Technology. And we also have Yahoo Finance's Anjalee Khemlani joining the conversation.
And Dr. Christiansen, let's just talk about this test, I mean, the fact that it can produce results in 15 minutes. It doesn't require lab equipment. Abbott saying that it's going to be able to produce 50 million a month by October. How big of a game changer is this?
SOREN CHRISTIANSEN: Yeah, to me this is really a game changer. So you pointed out a couple of points with this test. So access should not be a problem. They have promised to manufacture 50 million per months.
Timing should not be a problem. And I would add that the accuracy of the test, as far as I've been watching, is 98%. So it's very reliable. So when you get the results, you can basically trust that you are positive or you are negative. So this is really fantastic to me.
For more on this transcript please click:
About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Connect with Yahoo Finance:
#coronavirustest #COVID19testing #rapidcoronavirustesting
Video Transcript
SEANA SMITH: Let's get to another big story of the day. We talk about all these factors that are influencing the market. One, we had the Fed, but then we also had this big announcement out from Abbott. And we saw the reaction in Abbot's shares today, the stock up almost 8% on this news. Now, the news coming that Abbott has now gained FDA authorization for a $5 rapid coronavirus test.
Now, here to talk a little bit more about this and also finding a COVID-19 vaccine, I want to bring in Dr. Soren Christiansen, former Head of Vaccines at Merck. He's now the CEO of Sharps Technology. And we also have Yahoo Finance's Anjalee Khemlani joining the conversation.
And Dr. Christiansen, let's just talk about this test, I mean, the fact that it can produce results in 15 minutes. It doesn't require lab equipment. Abbott saying that it's going to be able to produce 50 million a month by October. How big of a game changer is this?
SOREN CHRISTIANSEN: Yeah, to me this is really a game changer. So you pointed out a couple of points with this test. So access should not be a problem. They have promised to manufacture 50 million per months.
Timing should not be a problem. And I would add that the accuracy of the test, as far as I've been watching, is 98%. So it's very reliable. So when you get the results, you can basically trust that you are positive or you are negative. So this is really fantastic to me.
For more on this transcript please click:
About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Connect with Yahoo Finance:
Комментарии